Binding Interactions of Peptide Aptamers

Roger R.C. New, Tam T.T. Bui, Michal Bogus

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Peptide aptamers are short amino acid chains that are capable of binding specifically to ligands in the same way as their much larger counterparts, antibodies. Ligands of therapeutic interest that can be targeted are other peptide chains or loops located on the surface of protein receptors (e.g., GCPR), which take part in cell-to-cell communications either directly or via the intermediary of hormones or signalling molecules. To confer on aptamers the same sort of conformational rigidity that characterises an antibody binding site, aptamers are often constructed in the form of cyclic peptides, on the assumption that this will encourage stronger binding interactions than would occur if the aptamers were simply linear chains. However, no formal studies have been conducted to confirm the hypothesis that linear peptides will engage in stronger binding interactions with cyclic peptides than with other linear peptides. In this study, the interaction of a model cyclic decamer with a series of linear peptide constructs was compared with that of a linear peptide with the same sequence, showing that the cyclic configuration does confer benefits by increasing the strength of binding.

Original languageEnglish
JournalMolecules (Basel, Switzerland)
Issue number24
Publication statusPublished - 21 Dec 2020


  • cyclic peptide
  • fluorescence enhancement
  • hydrogen bond
  • lipo-amino acid
  • peptide aptamer
  • peptide therapeutics


Dive into the research topics of 'Binding Interactions of Peptide Aptamers'. Together they form a unique fingerprint.

Cite this